NCT04017442View on ClinicalTrials.gov

Neuraxial Preservative Free Morphine for Normal Spontaneous Vaginal Delivery

PHASE4CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

October 19, 2019

Primary Completion Date

August 31, 2023

Study Completion Date

August 31, 2023

Conditions
Postpartum PainPostpartum DepressionOpioid Consumption
Interventions
DRUG

Preservative Free Morphine

After delivery of the baby patients will receive via the epidural catheter prior to its removal.

DRUG

Saline

After delivery of the baby patients will receive via the epidural catheter prior to its removal.

Trial Locations (1)

10029

Mount Sinai Hospital, New York

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT04017442 - Neuraxial Preservative Free Morphine for Normal Spontaneous Vaginal Delivery | Biotech Hunter | Biotech Hunter